Holen Sie sich die Stockscreener-App
33.92
1.22%
0.41
Korsana Biosciences, Inc. Common Stock Aktie (KRSA) Neueste Nachrichten
A passive stake above 5% in Korsana Biosciences (KRSA) is reported by FMR LLC in an amendment. - Stock Titan
Korsana Biosciences (NASDAQ: KRSA) director to sell 100 more shares after 2,139 sold recently - Stock Titan
After two September sales, a Korsana Biosciences (KRSA) director proposes selling 4,903 more shares. - Stock Titan
General Atlantic’s stake in Korsana (CYCN) comes with a strict ownership cap - Stock Titan
Korsana Biosciences (CYCN) director proposes $74.8K stock sale - Stock Titan
A fund reports a 6.1% passive stake in Korsana Biosciences (CYCN), with the investor's identity detailed in the filing. - Stock Titan
Nearly 10% of Korsana Biosciences (CYCN) is tied to one investor group, but its ownership is capped below that line. - Stock Titan
Diluted net income available to common stockholders of Korsana Biosciences, Inc. – NASDAQ:KRSA - TradingView
Korsana Biosciences, Inc. Statistics – NASDAQ:KRSA - TradingView
Investor gains significant stake and board power at Korsana Biosciences (CYCN) - Stock Titan
Korsana Biosciences, Inc. (KRSA) Company Information - Simply Wall Street
Why a 9.99% cap now limits a key Korsana (CYCN) holder - Stock Titan
CFO option stakes detailed at Korsana Biosciences (CYCN) after merger - Stock Titan
Merger gives Korsana Biosciences (CYCN) CMO options expiring in 2036 - Stock Titan
Korsana Biosciences (CYCN) director holds merger-issued option - Stock Titan
New Korsana Biosciences (CYCN) director reports 28,805-share option - Stock Titan
Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million - The Manila Times
CYCN Stock Explodes 313% on April 1 After Cyclerion-Korsana Merger Deal for Alzheimer's Pipeline - International Business Times Australia
Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement - Business Wire
Why is Biotech Stock Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) Gaining? - Investorideas.com
Cyclerion Therapeutics and Korsana Biosciences To Merge - citybiz
Cyclerion Therapeutics and Korsana Biosciences to merge - The Pharma Letter
CYCN Merges with Korsana Biosciences for Strategic Growth - GuruFocus
1.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):